Karyopharm Therapeutics (NASDAQ:KPTI) reported its Q4 earnings results on Tuesday, February 8, 2022 at 07:00 AM.
Here's what investors need to know about the announcement.
Earnings
Karyopharm Therapeutics beat estimated earnings by 193.88%, reporting an EPS of $0.46.
Revenue was up $91.17 million from the same period last year.
Past Earnings Performance
Last quarter the company missed on EPS by $0.02, which was followed by a 0.38% increase in the share price the next day.
Here's a look at Karyopharm Therapeutics's past performance:
| Quarter | Q3 2021 | Q2 2021 | Q1 2021 | Q4 2020 |
|---|---|---|---|---|
| EPS Estimate | -0.67 | -0.74 | -0.71 | -0.59 |
| EPS Actual | -0.69 | -0.71 | -0.77 | -0.59 |
| Revenue Estimate | 25.80M | 25.64M | 25.17M | 29.37M |
| Revenue Actual | 37.69M | 22.60M | 23.26M | 35.10M |
To track all upcoming earnings announcements, click to use Benzinga Earnings Calendar.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
